Premium
Essure ® sterilization associated with endometrial ablation
Author(s) -
Donnadieu A.C.,
Deffieux X.,
Gervaise A.,
Faivre E.,
Frydman R.,
Fernandez H.
Publication year - 2007
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/j.ijgo.2007.02.009
Subject(s) - essure , medicine , sterilization (economics) , endometrial ablation , gynecology , obstetrics , population , hysterectomy , surgery , family planning , research methodology , foreign exchange market , foreign exchange , environmental health , monetary economics , economics
Objective : To evaluate the feasibility and the outcome of Essure ® sterilization associated with different techniques of endometrial ablation. Method : Retrospective study conducted among 23 women with confirmed menometrorrhagia and with the desire for or the medical need for permanent tubal sterilization. Patients underwent combined hysteroscopic placement of Essure ® and hysteroscopic endometrial resection procedures: ThermaChoice ® ( n = 14), NovaSure ® ( n = 4), Hydrothermablator ® ( n = 2) and endometrial resection using monopolar energy ( n = 1), or bipolar energy ( n = 2). Results : Fallopian tubes were successfully cannulated bilaterally in 87% of the cases (20/23). No adverse event was reported. Adequate bilateral occlusion was confirmed for all patients (20/20) by 3D ultrasound and pelvic X‐ray at a 3‐month follow‐up. Furthermore, 85% of these patients were satisfied with the results of the procedure, all experiencing a significant reduction in menstrual blood loss (Higham blood loss score). Conclusion : Combining EA and hysteroscopic sterilization seems to be feasible and efficient in patients with menometrorrhagia.